Doseology Sciences Inc. (DOSEF)
USD 0.14
(0.0%)
USD 0.14
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -1.25 Million CAD | -10.89% |
| 2021 | -1.12 Million CAD | 62.96% |
| 2020 | -3.04 Million CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -1.11 Million CAD | 6.79% |
| 2023 Q1 | -1.19 Million CAD | 4.71% |
| 2022 FY | -1.25 Million CAD | -10.89% |
| 2022 Q4 | -1.25 Million CAD | -37.41% |
| 2022 Q3 | -910.57 Thousand CAD | 11.66% |
| 2022 Q2 | -1.03 Million CAD | 2.62% |
| 2022 Q1 | -1.05 Million CAD | 6.19% |
| 2021 Q1 | -2.44 Million CAD | 19.66% |
| 2021 FY | -1.12 Million CAD | 62.96% |
| 2021 Q4 | -1.12 Million CAD | 23.22% |
| 2021 Q3 | -1.46 Million CAD | 18.54% |
| 2021 Q2 | -1.8 Million CAD | 26.28% |
| 2020 Q4 | -3.04 Million CAD | 0.0% |
| 2020 FY | -3.04 Million CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 107.938% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 130.384% |
| SQZ Biotechnologies Company | -36.23 Million USD | 96.547% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 102.924% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 80.154% |
| Mesoblast Limited | 55.85 Million USD | 102.24% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 234.947% |
| Genus plc | 190.6 Million USD | 100.656% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 155.962% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 203.074% |
| Marizyme, Inc. | 18.56 Million USD | 106.738% |
| ContraFect Corporation | -6.02 Million USD | 79.237% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 284.001% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 1029.304% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 208.289% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 155.802% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 122.741% |
| MultiCell Technologies, Inc. | 90.04 USD | 1389711.284% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -70.469% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 109.665% |
| EV Biologics, Inc. | 1.36 Million USD | 191.464% |
| Q BioMed Inc. | 4.06 Million USD | 130.818% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 104.095% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 301.041% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 224.163% |
| Biomind Labs Inc. | 711.4 Thousand USD | 275.879% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Pharming Group N.V. | 109.8 Million USD | 101.139% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 109.77% |
| Skye Bioscience, Inc. | -5.72 Million USD | 78.131% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 245.448% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 994.972% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 122.152% |
| IMV Inc. | 7.67 Million USD | 116.312% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 6397.911% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 156.822% |
| GB Sciences, Inc. | 1.74 Million USD | 171.607% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -580.788% |
| HST Global, Inc. | 96.79 Thousand USD | 1392.662% |
| CSL Limited | 10.52 Billion USD | 100.012% |
| Halberd Corporation | 144.72 Thousand USD | 964.564% |
| Enzolytics Inc. | 981.65 Thousand USD | 227.459% |
| Resverlogix Corp. | 6.45 Million USD | 119.396% |
| Affymax, Inc. | -5.59 Million USD | 77.645% |
| SYBLEU INC | 473.71 Thousand USD | 364.127% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -85.89% |
| argenx SE | -2.02 Billion USD | 99.938% |
| MetaStat, Inc. | - USD | Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 102.881% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 97.339% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 146.194% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 85.846% |
| AVAX Technologies, Inc. | -5.9 Million USD | 78.805% |
| Zenith Capital Corp. | 10.06 Thousand USD | 12532.492% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.882% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 724.255% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 152.439% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 860.57% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 102.067% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 162.579% |
| Adynxx, Inc. | - USD | Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | 51.316% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 447.837% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 106.171% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -6730.473% |
| BioStem Technologies, Inc. | 4.47 Million USD | 127.979% |
| ONE Bio Corp. | 9.04 Million USD | 113.841% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 721.705% |
| Burzynski Research Institute, Inc. | -1310.00 USD | -95411.908% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 706.742% |
| Agentix Corp. | 37.63 Thousand USD | 3424.934% |
| LadRx Corporation | -2.03 Million USD | 38.56% |
| Cell Source, Inc. | 9.23 Million USD | 113.553% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -6030.958% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 296.989% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 296.989% |
| NovAccess Global Inc. | 2.17 Million USD | 157.435% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 117.695% |
| Itoco Inc. | 228.3 Thousand USD | 648.041% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 1020.079% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 125.241% |
| Kadimastem Ltd | -253.1 Thousand USD | -394.349% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 411.362% |
| CytoDyn Inc. | 20.26 Million USD | 106.175% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -193285.781% |
| Mobile Lads Corp. | 484.23 Thousand USD | 358.39% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -13399.785% |
| Qrons Inc. | 351.42 Thousand USD | 456.036% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 116.237% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -401.244% |
| Rebus Holdings, Inc. | 305 Thousand USD | 510.231% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 128.073% |
| International Stem Cell Corporation | 2.59 Million USD | 148.309% |
| Bioxytran, Inc. | 1.89 Million USD | 165.891% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 2104.72% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 157.371% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 136.436% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 114.629% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 261.946% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -0.096% |
| Neutra Corp. | 52.18 Thousand USD | 2497.543% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 49.731% |
| PureTech Health plc | -167.19 Million USD | 99.252% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -410.888% |
| IXICO plc | -4.44 Million USD | 71.849% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 109.465% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 102.281% |
| CSL Limited | 10.52 Billion USD | 100.012% |
| Cellectis S.A. | -43.81 Million USD | 97.145% |